Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Reversal of Resistance towards Cisplatin by Curcumin in Cervical Cancer Cells

  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Epigenetic regulators like histone deacetylases (1 and 2), and viral onco-proteins (E6/E7) are known to be overexpressed in cervical cancer cells. The present study was designed to investigate the effect of curcumin on HDACs (1 and 2) and HPV E6/E7 in the cervical cancer cell line SiHa and a drug resistant clone $SiHa^R$ (derived from SiHa). It was further intended to investigate whether curcumin could sensitize the cells towards cisplatin induced cell killing by modulation of multi drug resistant proteins like MRP1 and Pgp1. Curcumin inhibited HDACs, HPV expression and differentially increased acetylation and up-regulation of p53 in SiHa and $SiHa^R$, leading to cell cycle arrest at G1-S phase. Up-regulation of pRb, p21, p27 and corresponding inhibition of cyclin D1 and CDK4 were observed. Cisplatin resistance in $SiHa^R$ due to over-expression of MRP1 and Pgp1 was overcome by curcumin. Curcumin also sensitized both the cervical cancer cells towards cisplatin induced cell killing. Inhibition of HDACs and HPVs led to cell cycle arrest at G1/S phase by alteration of cell cycle regulatory proteins. Suppression of MRP1 and Pgp1 by curcumin resulted in sensitization of cervical cancer cells, lowering the chemotherapeutic dose of the drug cisplatin.

Keywords

References

  1. Basu P, Dutta S, Begum R, et al (2013). Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: A phase II randomized controlled study. Asian Pac J Cancer Prev, 14, 5753-59. https://doi.org/10.7314/APJCP.2013.14.10.5753
  2. Biswas J, Roy S, Mukherjee S, et al (2010). Indian spice curcumin may be an effective strategy to combat the genotoxicity of arsenic in swiss albino mice. Asian Pac J Cancer Prev, 11, 239-46.
  3. Brehm A, Nielsen SJ, Miska EA, et al (1999). The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. Embo J, 18, 2449-58. https://doi.org/10.1093/emboj/18.9.2449
  4. Cheah PL, Looi LM, Teoh KH, et al (2012). p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies. Asian Pac J Cancer Prev, 13, 469-72. https://doi.org/10.7314/APJCP.2012.13.2.469
  5. Chekhun VF, Lukyanova NY, Kovalchuk O, et al (2007). Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol Cancer Ther, 6, 1089-98. https://doi.org/10.1158/1535-7163.MCT-06-0663
  6. Choi BH, Kim CG, Lim Y, et al (2008). Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/$NF{\kappa}B$ pathway. Cancer Lett, 259, 111-18. https://doi.org/10.1016/j.canlet.2007.10.003
  7. Dai X-Z, Yin H-T, Sun L-F, et al (2013). Potential therapeutic efficacy of curcumin in liver cancer. Asian Pac J Cancer Prev, 14, 3855-59. https://doi.org/10.7314/APJCP.2013.14.6.3855
  8. Dong X, Mumper RJ (2010). Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine, 5, 597-615. https://doi.org/10.2217/nnm.10.35
  9. Ermakova SP, Kang BS, Choi BY, et al (2006). (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res, 66, 9260-69. https://doi.org/10.1158/0008-5472.CAN-06-1586
  10. Huang BH, Laban M, Leung CH, et al (2005). Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase1. Cell Death Differ, 12, 395-404. https://doi.org/10.1038/sj.cdd.4401567
  11. Jayshree RS, Sreenivas A, Tessy M et al (2009). Cell intrinsic and extrinsic factors in cervical carcinogenesis. Indian J Med Res, 130, 286-95.
  12. Kim H, Kim SN, Park YS, et al (2011). HDAC inhibitors downregulate MRP2 expression in multidrug resistant cancer cells: implication for chemosensitization. Int J Oncol, 38, 807-12.
  13. Kuo MT (2009). Redox regulation of multidrug resistance in cancer chemotherapy: Molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal, 11, 99-133. https://doi.org/10.1089/ars.2008.2095
  14. Lin Z, Bazzaro M, Wang M-C, et al (2009). Combination of proteasome and HDAC inhibitors for therapy of uterine cervical cancer. Clin Cancer Res, 15, 570-77. https://doi.org/10.1158/1078-0432.CCR-08-1813
  15. Longworth MS, Laimins LA (2004). The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papilloma virus type 31. J Virol, 78, 3533-41. https://doi.org/10.1128/JVI.78.7.3533-3541.2004
  16. Luczak MW, Jagodzinski PP (2008). Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells. Cancer Lett, 272, 53-60. https://doi.org/10.1016/j.canlet.2008.06.030
  17. Maher DM, Bell MC, O'Donnell EA, et al (2011). Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo(a)pyrene-induced upregulation of HPV-E7. Mol Carcinog, 50, 47-57. https://doi.org/10.1002/mc.20695
  18. Mahjoubi F, Akbari S (2013). Multidrug resistance-associated protein 1 predicts relapse in Iranian childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev, 13, 2285-9. https://doi.org/10.7314/APJCP.2012.13.5.2285
  19. Malumbres M, Barbacid M (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer, 9, 153-66. https://doi.org/10.1038/nrc2602
  20. Mizuguchi Y, Specht S, Lunz JG III, et al (2012). SPRR2a enhances p53 deacetylation through HDAC1 and downregulates p21 promoter activity. BMC Mol Cancer, 13, 20-9.
  21. Mockel J, Quaas J, Meisel H, Endres AS, Schneider V (2011). Human papillomavirus E6/E7 mRNA testing has higher specificity than liquid-based DNA testing in the evaluation of cervical intraepithelial neoplasia. Anal Quant Cytol Histol, 33, 311-5.
  22. Mukherjee S, Sarkar R, Biswas J, Roy M (2012) Curcumin inhibits histone deacetylase leading to cell cycle arrest and apoptosis via up-regulation of p21 in breast cancer cells. Int J Green Nanotech, 4, 183-97. https://doi.org/10.1080/19430892.2012.691799
  23. Munger K, Basile JR, Duensing S, et al (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20, 7888-98. https://doi.org/10.1038/sj.onc.1204860
  24. Narisawa-Saito M, Kiyono T (2007). Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci, 98, 1505-11. https://doi.org/10.1111/j.1349-7006.2007.00546.x
  25. Raybould R, Fiander A, Hibbitts S (2011). Human papillomavirus integration and its role in cervical malignant progression. The Open Clinical Cancer J, 5, 1-17. https://doi.org/10.2174/1874189401105010001
  26. Roy M, Mukherjee S, Sarkar R, Biswas J (2011). Curcumin sensitizes chemotherapeutic drugs via modulation of PKC, telomerase, $NF{\kappa}B$ and HDAC in breast cancer. Ther Delivery, 2, 1275-93. https://doi.org/10.4155/tde.11.97
  27. Sahin K, Tuzcu M, Basak N, et al (2012). Sensitization of cervical cancer cells to cisplatin by genistein: The role of $NF{\kappa}B$ and Akt/mTOR signaling pathways. J Oncol, 2012, 1-6.
  28. Sarkar FH, Li Y (2006). Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res, 66, 3347-50. https://doi.org/10.1158/0008-5472.CAN-05-4526
  29. Singh M, Singh N (2011). Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells. Mol Cell Biochem, 347, 1-11. https://doi.org/10.1007/s11010-010-0606-3
  30. Singh M, Singh U, Mathur N, et al (2012). Expression of p-glycoprotein is positively correlated with p53 in human papilloma virus induced squamous intraepithelial lesions of uterine cervix: poor prognosis association. Asian Pac J Cancer Prev, 13, 6039-45. https://doi.org/10.7314/APJCP.2012.13.12.6039
  31. Song W, Jiang R, Zhao C-M (2012). Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cell. Asian Pac J Cancer Prev, 13, 5619-25. https://doi.org/10.7314/APJCP.2012.13.11.5619
  32. Subramanian N, Chinnappan S (2013). Prediction of promiscuous epitopes in the E6 protein of three high risk human papilloma viruses: a computational approach. Asian Pac J Cancer Prev, 14, 4167-75. https://doi.org/10.7314/APJCP.2013.14.7.4167
  33. Szakacs G, Paterson JK, Ludwig JA, et al (2006). Targeting multidrug resistance in cancer. Nat Rev Drug Discov, 5, 219-34. https://doi.org/10.1038/nrd1984
  34. Takai N, Kira N, Ishii T, et al (2011). Novel chemotherapy using histone deacetylase inhibitors in cervical cancer. Asian Pac J Cancer Prev, 12, 575-80.
  35. Tanaki T, Fukasawa K, Suzuki-Takahashi I, et al (2004). Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro. Biochem Biophys Res Commun, 316, 252-5. https://doi.org/10.1016/j.bbrc.2004.02.044
  36. Tyagi AK, Agarwal C, Chan DC, et al (2004). Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncol Reports, 11, 493-9.
  37. Vinod BS, Maliekal TT, Anto RJ (2013). Phytochemicals as chemosensitizers: from molecular mechanism to clinical significance. Antioxidants and Redox Signaling, 18, 1307-48. https://doi.org/10.1089/ars.2012.4573
  38. Wesierska-Gadek J, Krystof V (2009). Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia? Ann NY Acad Sci, 1171, 228-41. https://doi.org/10.1111/j.1749-6632.2009.04726.x
  39. Witt O, Deubzer HE, Milde T, et al (2009). HDAC family: What are the cancer relevant targets? Cancer Lett, 277, 8-21. https://doi.org/10.1016/j.canlet.2008.08.016
  40. Yin HT, Zhang DG, Wu XL, et al (2013). In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev, 14, 409-12. https://doi.org/10.7314/APJCP.2013.14.1.409
  41. Zhang E-Y, Tang X-D (2012). Human papillomavirus type 16/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer. Asian Pac J Cancer Prev, 13, 5363-9. https://doi.org/10.7314/APJCP.2012.13.11.5363
  42. Zhou X, Gu Y, Zhang S-L (2012). Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: A huge review and meta-analysis. Asian Pac J Cancer Prev, 13, 4909-14. https://doi.org/10.7314/APJCP.2012.13.10.4909

Cited by

  1. Bag-1L is a Stress-withstand Molecule Prevents the Downregulation of Mcl-1 and c-Raf Under Control of Heat Shock Proteins in Cisplatin Treated HeLa Cervix Cancer Cells vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4475
  2. EGF Reverses Multi-drug Resistance via the p-ERK Pathway in HepG2/ADM and SMMC7721/ADM Hepatocellular Carcinoma Models vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2619
  3. Role of Cytokines in Genesis, Progression and Prognosis of Cervical Cancer vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.3851
  4. Targeting Cancer with Nano-Bullets: Curcumin, EGCG, Resveratrol and Quercetin on Flying Carpets vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.3865
  5. Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing vol.6, pp.4, 2014, https://doi.org/10.1556/IMAS.6.2014.4.1
  6. Curcumin protects against lipopolysaccharide-induced vasoconstriction dysfunction via inhibition of thrombospondin-1 and transforming growth factor-β1 vol.9, pp.2, 2014, https://doi.org/10.3892/etm.2014.2105
  7. Curcumin and Emodin Down-Regulate TGF-β Signaling Pathway in Human Cervical Cancer Cells vol.10, pp.3, 2015, https://doi.org/10.1371/journal.pone.0120045
  8. Significance of p53, pRb and Ki-67 markers in Cervical intraepithelial lesion and Malignancy vol.2, pp.10, 2015, https://doi.org/10.7603/s40730-015-0024-y
  9. Signaling pathways in HPV-associated cancers and therapeutic implications vol.25, pp.10529276, 2015, https://doi.org/10.1002/rmv.1823
  10. Local, combination chemotherapy in prevention of cervical cancer recurrence after surgery by using nanofibers co-loaded with cisplatin and curcumin vol.5, pp.129, 2015, https://doi.org/10.1039/C5RA17230F
  11. Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features vol.43, pp.3, 2016, https://doi.org/10.1002/biof.1344
  12. Cucurmin, anticancer, & antitumor perspectives: A comprehensive review pp.1549-7852, 2018, https://doi.org/10.1080/10408398.2016.1252711
  13. C60 fullerene enhances cisplatin anticancer activity and overcomes tumor cell drug resistance vol.10, pp.2, 2017, https://doi.org/10.1007/s12274-016-1324-2
  14. Curcumin reduces mitomycin C resistance in breast cancer stem cells by regulating Bcl-2 family-mediated apoptosis vol.17, pp.1, 2017, https://doi.org/10.1186/s12935-017-0453-3
  15. The combination of curcumin and 5-fluorouracil in cancer therapy vol.41, pp.1, 2018, https://doi.org/10.1007/s12272-017-0979-x
  16. Epigenetic agents in combined anticancer therapy vol.10, pp.9, 2018, https://doi.org/10.4155/fmc-2017-0203
  17. A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer vol.5, pp.2296-861X, 2018, https://doi.org/10.3389/fnut.2018.00138